- Report
- September 2026
- 183 Pages
Global
From €3293EUR$3,545USD£2,755GBP
€3659EUR$3,939USD£3,061GBP
- Report
- September 2026
- 189 Pages
Global
From €3293EUR$3,545USD£2,755GBP
€3659EUR$3,939USD£3,061GBP
- Report
- January 2026
- 185 Pages
Global
From €3293EUR$3,545USD£2,755GBP
€3659EUR$3,939USD£3,061GBP
- Report
- January 2026
- 185 Pages
Global
From €3293EUR$3,545USD£2,755GBP
€3659EUR$3,939USD£3,061GBP
- Report
- January 2026
- 181 Pages
Global
From €3293EUR$3,545USD£2,755GBP
€3659EUR$3,939USD£3,061GBP
- Report
- February 2026
- 250 Pages
Global
From €4171EUR$4,490USD£3,489GBP
- Report
- July 2026
- 180 Pages
Global
From €4412EUR$4,750USD£3,691GBP
- Report
- October 2026
- 150 Pages
Global
From €5434EUR$5,850USD£4,546GBP
- Report
- October 2026
- 271 Pages
Global
From €5434EUR$5,850USD£4,546GBP
- Report
- October 2026
- 212 Pages
Global
From €5434EUR$5,850USD£4,546GBP
- Report
- October 2026
- 381 Pages
Global
From €5434EUR$5,850USD£4,546GBP
- Report
- October 2026
- 228 Pages
Global
From €5434EUR$5,850USD£4,546GBP
- Report
- October 2026
- 209 Pages
Global
From €5434EUR$5,850USD£4,546GBP
- Report
- October 2026
- 207 Pages
Global
From €5434EUR$5,850USD£4,546GBP
- Report
- October 2026
- 221 Pages
Global
From €5387EUR$5,800USD£4,507GBP
- Report
- October 2026
- 213 Pages
Global
From €5434EUR$5,850USD£4,546GBP
- Report
- October 2026
- 179 Pages
Global
From €5434EUR$5,850USD£4,546GBP
- Report
- October 2026
- 114 Pages
Global
From €5434EUR$5,850USD£4,546GBP
- Report
- October 2026
- 254 Pages
Global
From €5434EUR$5,850USD£4,546GBP
- Report
- October 2026
- 220 Pages
Global
From €5434EUR$5,850USD£4,546GBP

The Transcriptomics market is a segment of the biotechnology industry that focuses on the study of gene expression. It involves the analysis of the transcriptome, which is the set of all RNA molecules in a cell. This includes mRNA, tRNA, and rRNA. Transcriptomics is used to study gene expression, regulation, and function. It is used to identify and characterize genes, as well as to understand the role of genes in disease and development. Transcriptomics can also be used to identify biomarkers for diagnosis and prognosis, and to develop new therapeutic targets.
Some companies in the Transcriptomics market include Illumina, Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, and QIAGEN. Show Less Read more